BVMF/P1RG34 (BVMF/P1RG34)

Brazil Stock Exchange: BVMF/P1RG34 · BRL

R$83.0

+3.36 (+4.2%)· Recorded snapshot

Market cap	11.9B
Revenue (ttm)	21.4B
Net income (ttm)	-9B
EPS (ttm)	-R$67.5
P/E (forward)	6.7x
Dividend	R$4.28 (5.16%)
Volume	1
Beta	0.69

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.4B
Net income (ttm): -9B
EPS (ttm): -R$67.5
P/E (forward): 6.7x
Market cap: 11.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E6.7

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-48.7

P25 n/aP50 n/aP75 n/a

ROIC4.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/P1RG34 indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Ireland
Country code	BR
Earnings date	2026-11-04
Employees	8,100
Employees change	-279
Employees growth	-3.33%
Enterprise value	BRL 28.4B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-27
First seen	2026-05-10
Fiscal year end	December
Founded	1887
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	BRP1RGBDR007
Last earnings date	2026-08-05
Last refreshed	2026-10-29
Market cap	BRL 11.9B
Next earnings date	2026-11-04
Price	BRL 83.04
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-19
Symbol	bvmf/P1RG34
Website	https://www.perrigo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-81.29%
EV/EBIT	18.91x
EV/EBITDA	7.97x
EV/FCF	46.09x
EV/Sales	1.28x
FCF / EV yield	2.17%
FCF yield	5.19%
Forward P/E	6.73x
P/(FCF - SBC) ratio	31.96x
P/(OCF - SBC) ratio	15.45x
P/B ratio	0.91x
P/FCF ratio	19.26x
P/OCF ratio	11.72x
P/S ratio	0.55x
Price/EBITDA ratio	3.73x
Sector forward P/E	11.07x
Sector P/E	40.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.74%
EBITDA margin	14.85%
FCF margin	2.75%
Gross margin	33.26%
Operating margin	6.74%
Pretax margin	-38.9%
Profit margin	-41.85%
Profit per employee	BRL -1.1M
Profitable quarters	1
Revenue per employee	BRL 2.6M
ROA	1.97%
ROA (5Y)	2.11%
ROCE	4.26%
ROE	-48.75%
ROE (5Y)	-9.47%
ROIC	4.83%
ROIC (5Y)	2.2%
SBC / revenue	1.14%
Tax / revenue	2.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
FCF growth	-50.68%
FCF growth (Q)	20.46%
FCF growth 3Y	-20.4%
Gross profit growth	-10.79%
Gross profit growth (Q)	-13.5%
Gross profit growth 3Y	-5.06%
Gross profit growth 5Y	-1.29%
Net income growth quarters	1
Net income growth years	0
OCF growth	-46.45%
OCF growth (Q)	8.83%
OCF growth 10Y	-7.56%
OCF growth 3Y	-14.83%
OCF growth 5Y	16.49%
Operating income growth	-33.72%
Operating income growth (Q)	-29.7%
Operating income growth 3Y	-0.31%
Operating income growth 5Y	4.71%
Revenue growth	-4.19%
Revenue growth (Q)	-3.17%
Revenue growth (QoQ)	5.53%
Revenue growth 10Y	-2.47%
Revenue growth 3Y	-3.62%
Revenue growth 5Y	0.48%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -396.7M
Depreciation and amortization	BRL 1.8B
EBIT	BRL 1.4B
EBITDA	BRL 3.2B
EPS	BRL -67.50
Financing cash flow	BRL -2.8B
Free cash flow	BRL 616.2M
Free cash flow minus SBC	BRL 371.4M
Gross profit	BRL 7.1B
Income taxes	BRL 468.5M
Investing cash flow	BRL 1.5B
Net borrowing	BRL -1.9B
Net cash flow	BRL -281.5M
Net income	BRL -9B
Operating cash flow minus SBC	BRL 768.1M
Operating income	BRL 1.4B
Revenue	BRL 21.4B
Stock-based compensation	BRL 244.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.42
Book value per share	BRL 93.69
Debt / EBITDA	5.24
Debt / equity	1.38
Debt / FCF	29.14
Goodwill	BRL 9.2B
Interest coverage	1.4
Long-term assets	BRL 26.1B
Long-term liabilities	BRL 20.6B
Net cash (debt)	BRL -15.9B
Net cash / market cap	-133.88%
Net debt / EBITDA	5
Net debt / equity	1.22
Net debt / FCF	25.79
Piotroski F-Score	6
Property, plant and equipment	BRL 5.5B
Shareholders' equity	BRL 13B
Tangible book value	BRL -7.1B
Tangible book value per share	BRL -51.09
Total assets	BRL 39.3B
Total cash	BRL 2.1B
Total debt	BRL 18B
Total liabilities	BRL 26.3B
WACC	5.92%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	BRL 13.3B
Current liabilities	BRL 5.7B
Current ratio	2.32
Inventory turnover	2.43
Net working capital	BRL 5.3B
Quick ratio	1.09
Working capital	BRL 7.2B
Working capital turnover	14.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.73%
Dividend growth	-2.46%
Dividend growth (3Y)	0.46%
Dividend growth (5Y)	5.14%
Dividend growth years	5
Dividend payment date	2026-09-21
Dividend payment years	7
Dividend payout frequency	Quarterly
Dividend per share	BRL 4.28
Dividend yield	5.16%
Ex-dividend date	2026-08-27
Last dividend	BRL 0.18
Shareholder yield	4.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 92.17
1D price change	4.22%
1M price change	14.86%
1M total return	14.86%
1W price change	7.96%
1W total return	7.96%
1Y price change	-31.12%
1Y return CAGR	-26.03%
1Y total return	-26.01%
20-day SMA	BRL 61.77
200-day SMA	BRL 129.23
3M price change	63.79%
3M total return	67.31%
3Y price change	-44.5%
3Y return CAGR	-14.1%
3Y total return	-36.61%
50-day SMA	BRL 58.50
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 112.00
52-week high date	2025-10-31
52-week low	BRL 49.00
52-week low date	2026-06-23
5Y price change	-65.98%
5Y return CAGR	-16.58%
5Y total return	-59.6%
6M price change	42.09%
6M total return	47.98%
All-time high	BRL 270.15
All-time high date	2020-02-26
All-time low	BRL 49.00
All-time low date	2026-06-23
Average true range (ATR)	BRL 3.02
Average volume	90.4
Beta (5Y)	0.69
Change from 52-week high	-25.86%
Change from 52-week low	69.47%
Change from all-time high	-69.26%
Change from all-time low	69.47%
Change from open	0%
Day's gap	4.22%
Dollar volume	BRL 83.04
High price	BRL 83.04
Low price	BRL 83.04
Monthly RSI	38.68
Open price	BRL 83.04
Previous close	BRL 79.68
Price vs 150-day SMA	-9.91%
Price vs 20-day SMA	34.43%
Price vs 200-day SMA	-35.74%
Price vs 50-day SMA	41.95%
Relative volume	0.01
RSI	77.22
Sharpe ratio	-0.61
Sortino ratio	-0.86
Volume	1
Weekly RSI	45.94
YTD price change	7.91%
YTD total return	14.12%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	138.1M
Shares change (QoQ)	0.65%
Shares change (YoY)	0.73%
Shares held by insiders	0.47%
Shares held by institutions	111.24%
Short ratio	8.8 days

Deeper analysis on BVMF/P1RG34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/P1RG34 report

Is a complete BVMF/P1RG34 research report available?

No complete published report is available for bvmf/P1RG34 (BVMF/P1RG34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/P1RG34 (BVMF/P1RG34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/P1RG34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/P1RG34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/P1RG34

Frequently asked questions